Inflammatory response after neurosurgery

Best Practice and Research: Clinical Anaesthesiology

Volumn 18, Issue 3, 2004, Pages 407-424

  Mutlu, Leman K ^a   Woiciechowsky, Christian ^a   Bechmann, Ingo ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Beneficial autoimmunity; Central nervous system inflammation; Cerebrospinal fluid cytokines; Myelin inhibiting antibodies; Systemic immunodepression

Indexed keywords

ADRENALIN; DEXAMETHASONE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GLUCOCORTICOID; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MIFEPRISTONE; MYELIN; NORADRENALIN; PADGEM PROTEIN; PROPRANOLOL; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTING CELL; ANTIINFLAMMATORY ACTIVITY; AXONAL INJURY; BLOOD BRAIN BARRIER; BRAIN CIRCULATION; BRAIN INJURY; CEREBROSPINAL FLUID ANALYSIS; COMPLEMENT SYSTEM; COMPUTER ASSISTED TOMOGRAPHY; CYTOKINE PRODUCTION; DIAGNOSTIC IMAGING; DISEASE SEVERITY; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOREACTIVITY; INTRACRANIAL PRESSURE; MOLECULAR INTERACTION; NERVE REGENERATION; NEUROSURGERY; NONHUMAN; POSTOPERATIVE INFLAMMATION; PRIORITY JOURNAL; REVIEW; SPINAL CORD INJURY;

ANIMALS; CENTRAL NERVOUS SYSTEM; CYTOKINES; HUMANS; INFLAMMATION; NERVOUS SYSTEM DISEASES; NEUROSURGICAL PROCEDURES; POSTOPERATIVE COMPLICATIONS;

EID: 3242680527     PISSN: 15216896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpa.2003.12.003     Document Type: Review

References (90)

1. Povlishock J.T. Christman C.W. The pathobiology of traumatically induced axonal injury in animals and humans: a review of current thoughts Journal of Neurotrauma 12 1995 555-564
2. Dumont A.S. Dumont R.J. Chow M.M. et al. Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation Neurosurgery 53 2003 123-133
3. Bayir H. Kochanek P.M. Clark R.S. Traumatic brain injury in infants and children: mechanisms of secondary damage and treatment in the intensive care unit Critical Care Clinics 19 2003 529-549
4. Lenzlinger P.M. Morganti-Kossmann M.C. Laurer H.L. McIntosh T.K. The duality of the inflammatory response to traumatic brain injury Molecular Neurobiology 24 2001 169-181
5. Schwartz M. Moalem G. Leibowitz-Amit R. Cohen I.R. Innate and adaptive immune responses can be beneficial for CNS repair Trends in Neurosciences 22 1999 295-299
6. Bechmann I. Nitsch R. Plasticity following lesion: help and harm from the immune system Restorative Neurology and Neuroscience 19 2001 189-198
7. Cserr H.F. Knopf P.M. Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view Immunology Today 13 1992 507-512
8. Hickey W.F. Basic principles of immunological surveillance of the normal central nervous system Glia 36 2001 118-124
9. Csuka E. Hans V.H. Ammann E. et al. Cell activation and inflammatory response following traumatic axonal injury in the rat Neuroreport 11 2000 2587-2590
10. Schmitt A.B. Buss A. Breuer S. et al. Major histocompatibility complex class II expression by activated microglia caudal to lesions of descending tracts in the human spinal cord is not associated with a T cell response Acta Neuropathologica 100 2000 528-536
11. Prins R.M. Liau L.M. Immunology and immunotherapy in neurosurgical disease Neurosurgery 53 2003 144-152
12. Stoll G. Jander S. Schroeter M. Detrimental and beneficial effects of injury-induced inflammation and cytokine expression in the nervous system Advances in Experimental Medicine and Biology 513 2002 87-113
13. Bechmann I. Nitsch R. Identification of phagocytic glial cells after lesion-induced anterograde degeneration using double-fluorescence labeling: combination of axonal tracing and lectin or immunostaining Histochemistry and Cell Biology 107 1997 391-397
14. Hailer N.P. Heppner F.L. Haas D. Nitsch R. Astrocytic factors deactivate antigen presenting cells that invade the central nervous system Brain Pathology 8 1998 459-474
15. Dirnagl U. Iadecola C. Moskowitz M.A. Pathobiology of ischaemic stroke: an integrated view Trends in Neurosciences 22 1999 391-397
16. Holmin S. Soderlund J. Biberfeld P. Mathiesen T. Intracerebral inflammation after human brain contusion Neurosurgery 42 1998 291-298
17. Schnell L. Fearn S. Klassen H. et al. Acute inflammatory responses to mechanical lesions in the CNS: differences between brain and spinal cord European Journal of Neuroscience 11 1999 3648-3658
18. Stahel P.F. Morganti-Kossmann M.C. Kossmann T. The role of the complement system in traumatic brain injury Brain Research. Brain Research Reviews 27 1998 243-256
19. Kaczorowski S.L. Schiding J.K. Toth C.A. Kochanek P.M. Effect of soluble complement receptor-1 on neutrophil accumulation after traumatic brain injury in rats Journal of Cerebral Blood Flow and Metabolism 15 1995 860-864
20. Morganti-Kossmann M.C. Rancan M. Otto V.I. et al. Role of cerebral inflammation after traumatic brain injury: a revisited concept Shock 16 2001 165-177
21. Otero G.C. Merrill J.E. Cytokine receptors on glial cells Glia 11 1994 117-128
22. Kossmann T. Hans V.H. Imhof H.G. et al. Intrathecal and serum interleukin-6 and the acute-phase response in patients with severe traumatic brain injuries Shock 4 1995 311-317
23. Woiciechowsky C. Asadullah K. Nestler D. et al. Different release of cytokines into the cerebrospinal fluid following surgery for intra- and extra-axial brain tumours Acta Neurochirurgica 139 1997 619-624
24. Arand M. Melzner H. Kinzl L. et al. Early inflammatory mediator response following isolated traumatic brain injury and other major trauma in humans Langenbecks Archives of Surgery 386 2001 241-248
25. Csuka E. Morganti-Kossmann M.C. Lenzlinger P.M. et al. IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: relationship to IL-6, TNF-alpha, TGF-beta1 and blood-brain barrier function Journal of Neuroimmunology 101 2 1999 211-221
26. Shohami E. Bass R. Wallach D. et al. Inhibition of tumor necrosis factor alpha (TNFalpha) activity in rat brain is associated with cerebroprotection after closed head injury Journal of Cerebral Blood Flow and Metabolism 16 1996 378-384
27. Scherbel U. Raghupathi R. Nakamura M. et al. Differential acute and chronic responses of tumor necrosis factor-deficient mice to experimental brain injury Proceedings of the National Academy of Sciences of the USA 96 1999 8721-8726
28. Shohami E. Ginis I. Hallenbeck J.M. Dual role of tumor necrosis factor alpha in brain injury Cytokine and Growth Factor Reviews 10 1999 119-130
29. de Waal Malefyt R. Abrams J. Bennett B. et al. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes Journal of Experimental Medicine 174 1991 1209-1220
30. Bell M.J. Kochanek P.M. Doughty L.A. et al. Interleukin-6 and interleukin-10 in cerebrospinal fluid after severe traumatic brain injury in children Journal of Neurotrauma 14 1997 451-457
31. Balasingam V. Yong V.W. Attenuation of astroglial reactivity by interleukin-10 Journal of Neuroscience 16 1996 2945-2955
32. Bethea J.R. Nagashima H. Acosta M.C. et al. Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats Journal of Neurotrauma 16 1999 851-863
33. Morganti-Kossmann M.C. Hans V.H. Lenzlinger P.M. et al. TGF-beta is elevated in the CSF of patients with severe traumatic brain injuries and parallels blood-brain barrier function Journal of Neurotrauma 16 1999 617-628
34. Olivares-Villagomez D. Wang Y. Lafaille J.J. Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis Journal of Experimental Medicine 188 1998 1883-1894
35. Beamer N.B. Coull B.M. Clark W.M. et al. Interleukin-6 and interleukin-1 receptor antagonist in acute stroke Annals of Neurology 37 1995 800-805
36. McKeating E.G. Andrews P.J. Signorini D.F. Mascia L. Transcranial cytokine gradients in patients requiring intensive care after acute brain injury British Journal of Anaesthesia 78 1997 520-523
37. Kossmann T. Stahel P.F. Lenzlinger P.M. et al. Interleukin-8 released into the cerebrospinal fluid after brain injury is associated with blood-brain barrier dysfunction and nerve growth factor production Journal of Cerebral Blood Flow and Metabolism 17 1997 280-289
38. Vila N. Castillo J. Davalos A. et al. Levels of anti-inflammatory cytokines and neurological worsening in acute ischemic stroke Stroke 34 2003 671-675
39. Woiciechowsky C. Schoning B. Cobanov J. et al. Early IL-6 plasma concentrations correlate with severity of brain injury and pneumonia in brain-injured patients Journal of Trauma 52 2002 339-345
40. Woiciechowsky C. Asadullah K. Nestler D. et al. Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury Nature Medicine 4 1998 808-813
41. Stahel P.F. Kossmann T. Joller H. et al. Increased interleukin-12 levels in human cerebrospinal fluid following severe head trauma Neuroscience Letters 249 1998 123-126
42. Maier B. Schwerdtfeger K. Mautes A. et al. Differential release of interleukines 6, 8, and 10 in cerebrospinal fluid and plasma after traumatic brain injury Shock 15 2001 421-426
43. Woiciechowsky C. Schöning B. Lanksch W.R. et al. Mechanisms of brain-mediated systemic anti-inflammatory syndrom causing immunodepression Journal of Molecular Medicine 11 1999 769-780
44. Besedovsky E. del Rey C.A. feedback between interleukin-1 and glucocorticoid hormones Science 233 1986 652-654
45. Sapolsky R. Rivier C. Yamamoto G. et al. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor Science 238 1987 522-524
46. Katsuura G. Gottschall P.E. Dahl R.R. Arimura A. Adrenocorticotropin release induced by intracerebroventricular injection of recombinant human interleukin-1 in rats: possible involvement of prostaglandin Endocrinology 122 1988 1773-1779
47. Besedovsky H.O. del Rey A. The cytokine-HPA axis feed-back circuit Zeitschrift fur Rheumatologie 59 supplement 2 2000 II/26-II/30
48. Tabardel Y. Duchateau J. Schmartz D. et al. Corticosteroids increase blood interleukin-10 levels during cardiopulmonary bypass in men Surgery 119 1996 76-80
49. Baybutt H.N. Holsboer F. Inhibition of macrophage differentiation and function by cortisol Endocrinology 127 1990 476-480
50. Elenkov I.J. Papanicolaou D.A. Wilder R.L. Chrousos G.P. Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications Proceedings of the Association of American Physicians 108 1996 374-381
51. McKay L.I. Cidlowski J.A. Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways Endocrine Reviews 20 1999 435-459
52. Kapcala L.P. Chautard T. Eskay R.L. The protective role of the hypothalamic-pituitary-adrenal axis against lethality produced by immune, infectious, and inflammatory stress Annals of the New York Academy of Sciences 771 1995 419-437
53. Rivier C. Vale W. Brown M. In the rat, interleukin-1 alpha and -beta stimulate adrenocorticotropin and catecholamine release Endocrinology 125 1989 3096-3102
54. Sundar S.K. Becker K.J. Cierpial M.A. et al. Intracerebroventricular infusion of interleukin 1 rapidly decreases peripheral cellular immune responses Proceedings of the National Academy of Sciences of the USA 86 1989 6398-6402
55. Woiciechowsky C. Schöning B. Daberkow N. et al. Brain-IL-1-beta induces local inflammation but systemic anti-inflammatory response through stimulation of both hypothalamic-pituitary-adrenal axis and sympathetic nervous system Brain Research 816 1999 563-571
56. Woiciechowsky C. Schöning B. Daberkow N. et al. Brain IL-1-beta increases neutrophil and decreases lymphocyte counts through stimulation of neuroimmune pathways Neurobiology of Disease 6 1999 200-208
57. Luger T.A. Scholzen T.E. Brzoska T. Bohm M. New insights into the functions of alpha-MSH and related peptides in the immune system Annals of the New York Academy of Sciences 994 2003 133-140
58. Elliott L.H. Brooks W.H. Roszman T.L. Inability of mitogen-activated lymphocytes obtained from patients with malignant primary intracranial tumors to express high affinity interleukin 2 receptors Journal of Clinical Investigation 86 1990 80-86
59. Woiciechowsky C. Asadullah K. Nestler D. et al. Diminished monocytic HLA-DR expression and ex vivo cytokine secretion capacity in patients with glioblastoma: effect of tumor extirpation Journal of Neuroimmunology 84 1998 164-171
60. Van Meir E.G. Cytokines and tumors of the central nervous system Glia 15 1995 264-288
61. Asadullah K. Woiciechowsky C. Döcke W.D. et al. Very low monocytic HLA-DR expression indicates high risk of infection - immunomonitoring for patients after neurosurgery and patients during high dose steroid therapy European Journal of Emergency Medicine 2 1996 184-190
62. Asadullah K. Woiciechowsky C. Döcke W.D. et al. Immunodepression following neurosurgical procedures Critical Care Medicine 23 1995 1976-1983
63. Elenkov I.J. Wilder R.L. Chrousos G.P. Vizi E.S. The sympathetic nerve - an integrative interface between two supersystems: the brain and the immune system Pharmacological Reviews 52 2000 595-638
64. Kawashima K. Fujii T. The lymphocytic cholinergic system and its biological function Life Sciences 72 2003 2101-2109
65. Sundar S.K. Cierpial M.A. Kilts C. et al. Brain IL-1-induced immunosuppression occurs through activation of both pituitary-adrenal axis and sympathetic nervous system by corticotropin-releasing factor Journal of Neuroscience 10 1990 3701-3706
66. Severn A. Rapson N.T. Hunter C.A. Liew F.Y. Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists Journal of Immunology 148 1992 3441-3445
67. Chelmicka-Schorr E. Kwasniewski M.N. Czlonkowska A. Sympathetic nervous system and macrophage function Annals of the New York Academy of Sciences 650 1992 40-45
68. Van der Poll T. Coyle S.M. Barbosa K. et al. Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia Journal of Clinical Investigation 97 1996 713-719
69. Wang H. Yu M. Ochani M. et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation Nature 421 2003 384-388
70. Kwidzinski E. Mutlu L.K. Kovac A. et al. Self-tolerance in the immune privileged CNS: lessons from the entorhinal cortex lesion model Journal of Neural Transmission Supplement 65 2003 29-49
71. Carson M.J. Reilly C.R. Sutcliffe J.G. Lo D. Mature microglia resemble immature antigen-presenting cells Glia 22 1998 72-85
72. Matyszak M.K. Denis-Donini S. Citterio S. et al. Microglia induce myelin basic protein-specific T cell anergy or T cell activation, according to their state of activation European Journal of Immunology 29 1999 3063-3076
73. Fischer H.G. Reichmann G. Brain dendritic cells and macrophages/microglia in central nervous system inflammation Journal of Immunology 166 2001 2717-2726
74. Wolf S.A. Gimsa U. Bechmann I. Nitsch R. Differential expression of costimulatory molecules B7-1 and B7-2 on microglial cells induced by Th1 and Th2 cells in organotypic brain tissue Glia 36 2001 414-420
75. Frotscher M. Heimrich B. Deller T. Sprouting in the hippocampus is layer-specific Trends in Neurosciences 20 1997 218-223
76. Schwab M.E. et al. Repairing the injured spinal cord Science 295 2002 1029-1031
77. Buss A. Schwab M.E. Sequential loss of myelin proteins during Wallerian degeneration in the rat spinal cord Glia 42 2003 424-432
78. Rapalino O. Lazarov-Spiegler O. Agranov E. et al. Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats Nature Medicine 4 1998 814-821
79. Moalem G. Leibowitz-Amit R. Yoles E. et al. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy Nature Medicine 5 1999 49-55
80. Huang D.W. McKerracher L. Braun P.E. David S. A therapeutic vaccine approach to stimulate axon regeneration in the adult mammalian spinal cord Neuron 24 1999 639-647
81. Hofstetter H.H. Sewell D.L. Liu F. et al. Autoreactive T cells promote post-traumatic healing in the central nervous system Journal of Neuroimmunology 134 2003 25-34
82. Hammarberg H. Lidman O. Lundberg C. et al. Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells Journal of Neuroscience 20 2000 5283-5291
83. Blight A.R. Miracles and molecules-progress in spinal cord repair Nature Neuroscience 5 supplement 2002 1051-1054
84. Popovich P.G. Guan Z. Wei P. et al. Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury Experimental Neurology 158 1999 351-365
85. Jones T.B. Basso D.M. Sodhi A. Pathological C.N.S. et al. autoimmune disease triggered by traumatic spinal cord injury: implications for autoimmune vaccine therapy Journal of Neuroscience 22 2002 2690-2700
86. Kipnis J. Yoles E. Schori H. et al. Neuronal survival after CNS insult is determined by a genetically encoded autoimmune response Journal of Neuroscience 21 2001 4564-4571
87. Kerschensteiner M. Gallmeier E. Behrens L. et al. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? Journal of Experimental Medicine 189 1999 865-870
88. Gimsa U. Peter S.V. Lehmann K. et al. Axonal damage induced by invading T cells in organotypic central nervous system tissue in vitro: involvement of microglial cells Brain Pathology 10 2000 365-377
89. Emerick A.J. Neafsey E.J. Schwab M.E. Kartje G.L. Functional reorganization of the motor cortex in adult rats after cortical lesion and treatment with monoclonal antibody IN-1 Journal of Neuroscience 23 2003 4826-4830
90. Schwab M.E. Increasing plasticity and functional recovery of the lesioned spinal cord Progress in Brain Research 137 2002 351-359